Le Lézard
Classified in: Science and technology, Covid-19 virus
Subject: SVY

5G is on the Fast-track, Spurred by COVID-19


CAMPBELL, Calif., Aug. 12, 2020 /PRNewswire/ -- Today Mobile Experts released an RRH Semiconductor Report that clocks the accelerating 5G system as it races toward a peak in 2021 and continued growth through 2025.

According to the 70-page report, Massive MIMO will be a major impetus for the breakneck RRHSEMI growth. The most significant beneficiary for the impressive market RRH Semiconductor market growth is the Power Amplifier (specifically using GaN technology), but Filters and ASIC/FPGA solutions will also benefit.

"In addition to overall product growth, we expect to see significant focus on the domestic semiconductor supply chain in China," commented Principal Analyst Dan McNamara. "The political climate between the US and China as well as effects of the COVID-19 pandemic will lead to an increased push to ramp up internal suppliers but also a disruption to parts that cannot be exactly replicated in the short term."

As with all rapidly developing markets, change comes with growth. According to the report, the sheer number of massive MIMO transceivers will drive a huge boost in the RF semiconductor market, though opportunities for individual suppliers could differ case by case due to uneven global deployment and regional strengths for each network OEM. Mobile Expert subscribers enjoy full access to the analysts behind the report, who have identified where the markets 'lumps' are and can break down specific cases.

"RFSoCs, power amplifiers and filters will see shipments more than double from 2019 to 2021. We will see a strong 5G market overall through 2025. Despite a few pockets of uneven growth, the inclusion of Massive MIMO will leave the baseline market at a higher level overall, essentially double what we had in LTE days," commented Principal Analyst Dan McNamara.

New to the RRH Semiconductor Report for 2020 is the inclusion of filter demand for both 5G and LTE systems. The analysis breaks down the technologies used (cavity, ceramic, and acoustic filter types) and the shipments of each as well as overall market value.

To create estimates and forecasts, Mobile Experts relies on direct input from more than 40 industry sources, including multiple top OEM vendors, mobile operators, and component suppliers. Mobile Experts used financial disclosures from publicly traded companies to assemble a quantitative view of the equipment market, and to establish estimates of the expected trends in the near future.

For more about this report, click here.

About Mobile Experts Inc.:
Mobile Experts provides insightful market analysis for the mobile infrastructure and mobile handset markets.  Our analysts are true Experts, who remain focused on topics where each analyst has 20 years of experience or more. Research topics center on technology introduction for radio frequency (RF) and communications innovation. Recent publications focus on RRH Semiconductors, RFFE, CBRS PAL Auction, Small Cells, 5G mm-wave, Private LTE and 5G,  Macro Base Stations, 5G Business case, Cellular IoT, CBRS Infrastructure and Devices, ORAN, URLLC and 5G IoT, Edge Computing, Big Picture IoT, Edge Computing for Enterprises, LPWA, Fixed Wireless, CRAN/VRAN, and more.

Contact:
Rachel Winningham
Mobile Experts Inc.
[email protected]
+1 (408) 540-7284
www.mobile-experts.net

 

SOURCE Mobile Experts


These press releases may also interest you

at 07:35
Arrowhead Pharmaceuticals, Inc. announced today that it has dosed the first subjects in a Phase 1/2a clinical trial (NCT06209177) of ARO-CFB, the company's investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and...

at 07:35
Fortive Corporation ("Fortive") today announced financial results for the first quarter of 2024. For the first quarter, net earnings were $207 million. For the same period, adjusted net earnings were $295 million, which excludes the $63 million...

at 07:20
Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza (H5N1) virus, considered to be potential future pandemic threatStudy will assess monovalent vaccine candidate, encoding an...

at 07:20
CureVac N.V. ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger...

at 07:05
Healthcare Services Group, Inc. today reported results for the three months ended March 31, 2024. Ted Wahl, Chief Executive Officer, stated, "Our team delivered strong first quarter results, building on our positive momentum in 2023. During the...

at 07:05
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. , today announced that positive results from the Phase 3 oral zoliflodacin trial will be highlighted in an oral presentation given by the Global Antibiotic Research & Development...



News published on and distributed by: